Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors (Q44258968)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors |
scientific article |
Statements
1 reference
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors (English)
1 reference
Sylvie Boutin
1 reference
Virginie Monteilhet
1 reference
Philippe Veron
1 reference
Christian Leborgne
1 reference
Olivier Benveniste
1 reference
Marie Françoise Montus
1 reference
Carole Masurier
1 reference
1 June 2010
1 reference
1 reference
Identifiers
1 reference